Skip to main content

Table 6 Patients with increased CRP and normal albumin level had a better median progression free survival and median overall survival than patients with normal CRP and decreased albumin level in the patients with GPS 1 (not statistically significant)

From: Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

 

Patients with increased CRP and normal albumin level (n= 87)

Patients with normal CRP and decreased albumin level (n= 24)

P-value

mPFS (months)

3.433

2.533

0.489

 

(95% CI 2.648-4.219)

(95% CI 0.000-5.284)

 

mOS (months)

8.9

8.7

0.915

 

(95% CI 7.003-10.930)

(95% CI 5.779-11.621)

 
  1. mPFS: median progression free survival, mOS: median overall survival, CRP: C-reactive protein